BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28887206)

  • 1. Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model.
    Nagaraja TN; Elmghirbi R; Brown SL; Schultz LR; Lee IY; Keenan KA; Panda S; Cabral G; Mikkelsen T; Ewing JR
    Magn Reson Imaging; 2017 Dec; 44():131-139. PubMed ID: 28887206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection.
    Chwang WB; Jain R; Bagher-Ebadian H; Nejad-Davarani SP; Iskander AS; VanSlooten A; Schultz L; Arbab AS; Ewing JR
    J Magn Reson Imaging; 2014 Nov; 40(5):1223-9. PubMed ID: 24421265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 glioma.
    Aryal MP; Nagaraja TN; Brown SL; Lu M; Bagher-Ebadian H; Ding G; Panda S; Keenan K; Cabral G; Mikkelsen T; Ewing JR
    NMR Biomed; 2014 Oct; 27(10):1230-8. PubMed ID: 25125367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging acute effects of bevacizumab on tumor vascular kinetics in a preclinical orthotopic model of U251 glioma.
    Nagaraja TN; Elmghirbi R; Brown SL; Rey JA; Schultz L; Mukherjee A; Cabral G; Panda S; Lee IY; Sarntinoranont M; Keenan KA; Knight RA; Ewing JR
    NMR Biomed; 2021 Jul; 34(7):e4516. PubMed ID: 33817893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
    Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
    Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative study.
    Yan N; Zheng Y; Yang C
    Drug Des Devel Ther; 2017; 11():2931-2936. PubMed ID: 29042753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in assessing glioblastoma microvasculature.
    Jia ZZ; Shi W; Shi JL; Shen DD; Gu HM; Zhou XJ
    Eur J Radiol; 2017 Feb; 87():120-124. PubMed ID: 28034567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters.
    Quarles CC; Gore JC; Xu L; Yankeelov TE
    Magn Reson Imaging; 2012 Sep; 30(7):944-53. PubMed ID: 22617148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
    Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
    Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T.
    Aryal MP; Nagaraja TN; Keenan KA; Bagher-Ebadian H; Panda S; Brown SL; Cabral G; Fenstermacher JD; Ewing JR
    Magn Reson Med; 2014 Jun; 71(6):2206-14. PubMed ID: 23878070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal evaluation of tumor microenvironment in rat focal brainstem glioma using diffusion and perfusion MRI.
    Magdoom KN; Delgado F; Bohórquez AC; Brown AC; Carney PR; Rinaldi C; Mareci TH; Ewing JR; Sarntinoranont M
    J Magn Reson Imaging; 2019 May; 49(5):1322-1332. PubMed ID: 30318760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of microvascular cerebral blood flux and late-stage tumor compartmentalization in 9L gliosarcoma using flow enhanced MRI.
    Reynaud O; Geffroy F; Ciobanu L
    NMR Biomed; 2013 Jun; 26(6):699-708. PubMed ID: 23335424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.
    Lemasson B; Christen T; Serduc R; Maisin C; Bouchet A; Le Duc G; Rémy C; Barbier EL
    Radiology; 2012 Dec; 265(3):743-52. PubMed ID: 22996750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI measurement of change in vascular parameters in the 9L rat cerebral tumor after dexamethasone administration.
    Ewing JR; Brown SL; Nagaraja TN; Bagher-Ebadian H; Paudyal R; Panda S; Knight RA; Ding G; Jiang Q; Lu M; Fenstermacher JD
    J Magn Reson Imaging; 2008 Jun; 27(6):1430-8. PubMed ID: 18504732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.
    Sun H; Xu Y; Xu Q; Duan J; Zhang H; Liu T; Li L; Chan Q; Xie S; Wang W
    Acad Radiol; 2019 Jul; 26(7):e134-e140. PubMed ID: 30268719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
    Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.
    Ewing JR; Brown SL; Lu M; Panda S; Ding G; Knight RA; Cao Y; Jiang Q; Nagaraja TN; Churchman JL; Fenstermacher JD
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):310-20. PubMed ID: 16079791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model.
    Darpolor MM; Molthen RC; Schmainda KM
    PLoS One; 2011 Jan; 6(1):e16621. PubMed ID: 21305001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.